Start your admissions process online today.
We understand treatment is an investment. Learn more about our payment options.
Contact us directly to ask about treatment options and speak to an admissions representative.
Start your recovery today!
Ozempic is a semaglutide drug that was approved by the Food and Drug Administration (FDA) in 2017, designed by Novo Nordisk to improve blood sugar levels (glucose), when used along with diet and exercise, for adults with Type 2 Diabetes.1 This class of drugs, semaglutide or glucagon-like peptide-1 (GLP-1) medications were created as receptor agonists for diabetes management.
After additional research and clinical trials, the FDA expanded its approval to note Ozempic’s indication to “reduce the risk of major cardiovascular events,” and “reduce the risk of kidney disease worsening” for adults with Type 2 Diabetes and Chronic Kidney Disease. Beyond this, the European Medicines Agency (EMA) granted a marketing authorization valid throughout the European Union for Ozempic as a Type 2 Diabetes drug in 2018.2
AMFM is here to help you or your loved one take the next steps towards an improved mental well-being.
There are a variety of different antidepressant medications that have been proven as effective treatment (in combination with psychological treatment) for depression. Some types of antidepressants are listed here, but inquire with a licensed medical professional or psychiatrist for detailed information on different treatments. Never take psychiatric medication unless it is prescribed to you, and be sure to consult with medical professionals in case of external risk factors.
Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SSNIs)are antidepressant medications that treat different neurotransmitters in order to block the reabsorption of serotonin or norepinephrine, keeping more of the chemicals in the synaptic cleft. Both are effective treatments for depression, but depend upon the individual, and should be approached with medical guidance and professional advice. If you’re currently on medications for any other medical conditions, it’s important to review any over-the-counter medications and their interactions with a medical professional.
A Mission For Michael (AMFM) provides treatment for adults experiencing various conditions. Depression support is a phone call away – call 866-478-4383 to learn about our current treatment options.
See our residences in Southern California’s Orange County & San Diego County.
Take a look at our homes on the east side of the Metro area in Washington County.
View our facilities in Fairfax County, VA within the DC metro area.
AMFM clinical teams offer medication management throughout mental health treatment for your convenience and safety. Trying to navigate the proper dosages, keep track of side effects, monitor organization and timely administration of medications at home can be challenging, dangerous and risky without clinical support or supervision. For those struggling with mental health disorders, clinical support can help take something off your plate–walking through mental health challenges is hard enough alone, so having compassionate clinical care on-hand 24/7.
AMFM Mental Health Treatment offers medication management as a part of the treatment plans, if you are attending an inpatient or outpatient in-person program. In this setting, AMFM staffs clinical professionals to help with medication management in order to ensure that none of your medications are having adverse effects, and to prevent any interactions between medications. As a result, you or your loved one can simply focus on your healing journey. If you’re ready to start your mental health journey, give us a call today.
Yes, most health insurance companies provide some form of coverage for depression treatment. This often includes both inpatient and outpatient care, depending on your symptoms. Coverage generally applies to therapy, counseling, and medication management services. Your plan may have limitations, exclusions, or required authorizations.
We encourage you to verify your coverage with AMFM Mental Health Treatment to understand the full scope of your benefits.
Insurance can be complicated but we are here to help. AMFM has over a decade of experience in the mental health field and is in-network with many large insurance providers.
By using our form, we can quickly determine if you are in-network at one of our facilities. Insurance benefits vary greatly depending on the policy you have, so we obtain a detailed quote of your coverage.
It usually takes between sixty to ninety minutes depending on the time of day.
Our team will check insurance coverage and determine the benefits available to you for mental health services.
We also have private pay options available.
"*" indicates required fields
100% Confidential
No Commitment
Instant Results
“News Details.” Novo Nordisk, www.novonordisk-us.com/media/news-archive/news-details.html?id=915253. Accessed 14 Apr. 2025.
“Ozempic.” European Medicines Agency (EMA), www.ema.europa.eu/en/medicines/human/EPAR/ozempic. Accessed 14 Apr. 2025.
Collins L, Costello RA. Glucagon-Like Peptide-1 Receptor Agonists. [Updated 2024 Feb 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551568/
“Weight Loss: Drugs like Ozempic May Be Linked to Lower Depression Risk.” Medical News Today, MediLexicon International, www.medicalnewstoday.com/articles/weight-loss-drugs-help-lower-depression-and-anxiety-risk. Accessed 14 Apr. 2025.
Neporent, Liz. “Ozempic and Other Weight Loss Drugs Linked to Antidepressant Use.” Psychiatrist.Com, Psychiatrist.com, 26 June 2024, www.psychiatrist.com/news/ozempic-and-other-weight-loss-drugs-linked-to-antidepressant-use/.
Center for Drug Evaluation and Research. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” U.S. Food and Drug Administration, FDA, www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss. Accessed 14 Apr. 2025.
Latif W, Lambrinos KJ, Patel P, et al. Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs) [Updated 2024 Feb 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572151/
“Medication Management Strategy: Intervention | Agency for Healthcare Research and Quality.” | Agency for Healthcare Research and Quality, https://www.ahrq.gov/patient-safety/reports/engage/interventions/medmanage.html. Accessed 3 March 2025.
We understand why you’d ask—there’s a lot of attention on GLP-1 medications right now. Research has shown conflicting findings, so there isn’t a clear, definitive answer. If you notice mood changes or depressive symptoms while taking Ozempic, we encourage you to talk with your prescribing provider and consider a mental health evaluation for support.
Please don’t try to manage it alone. Let your medical provider know about any mood shifts, and seek mental health support if symptoms of depression show up or intensify. If you’re experiencing thoughts of self-harm, treat that as urgent and get immediate help from local emergency services or an in-person medical professional right away.
We treat adults experiencing depression with structured, supportive programming that can include psychiatric care, therapy, and medication management as part of an individualized plan. Our team works to understand your symptoms, safety needs, and clinical history so treatment matches your level of care.
Medication management is a clinical process where professionals monitor and evaluate medications for effectiveness, side effects, and potential interactions. It can be especially helpful when depression is severe, when multiple prescriptions are involved, or when you want added support staying consistent and safe with your medication plan.
In many cases, yes—most insurance plans provide some level of coverage for depression treatment, which may include inpatient and outpatient care depending on medical necessity and your benefits. We can help verify coverage and walk you through what your plan may include, along with any authorizations or limitations.
At AMFM, we strive to provide the most up-to-date and accurate medical information based on current best practices, evolving information, and our team’s approach to care. Our aim is that our readers can make informed decisions about their healthcare.
Our reviewers are credentialed medical providers specializing and practicing behavioral healthcare. We follow strict guidelines when fact-checking information and only use credible sources when citing statistics and medical information. Look for the medically reviewed badge on our articles for the most up-to-date and accurate information.
If you feel that any of our content is inaccurate or out of date, please let us know at info@amfmhealthcare.com